1. Home
  2. SER vs GOAI Comparison

SER vs GOAI Comparison

Compare SER & GOAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$1.70

Market Cap

56.4M

Sector

Health Care

ML Signal

HOLD

Logo Eva Live Inc. Common Stock

GOAI

Eva Live Inc. Common Stock

BUY

Current Price

$1.55

Market Cap

62.0M

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
SER
GOAI
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
56.4M
62.0M
IPO Year
2024
2023

Fundamental Metrics

Financial Performance
Metric
SER
GOAI
Price
$1.70
$1.55
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $9.50
N/A
AVG Volume (30 Days)
28.7K
★ 111.5K
Earning Date
11-12-2026
11-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 966.67
EPS
N/A
★ N/A
Revenue
$130,000.00
★ $17,037,328.00
Revenue This Year
N/A
$14.45
Revenue Next Year
N/A
$53.85
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 132.14
82.59
52 Week Low
$1.22
$1.42
52 Week High
$5.29
$6.67

Technical Indicators

Market Signals
Indicator
SER
GOAI
Relative Strength Index (RSI) 35.23 36.08
Support Level $1.73 $1.42
Resistance Level $1.86 $2.66
Average True Range (ATR) 0.11 0.17
MACD -0.02 -0.02
Stochastic Oscillator 15.38 10.21

Price Performance

Historical Comparison
SER
GOAI

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

About GOAI Eva Live Inc. Common Stock

Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.

Share on Social Networks: